- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bret Jackson on Congress' Attempt to Curb Surprise Medical Billing
Attempts to curb surprise medical may still result in patients getting costs elsewhere, said Bret Jackson, president of the Economic Alliance for Michigan.
Attempts to curb surprise medical may still result in patients getting costs elsewhere, said Bret Jackson, president of the Economic Alliance for Michigan.
What is your view on the bill in Congress to reduce healthcare costs and how it approaches surprise medical billing?
So, the debate in Washington is whether or not we’re going to have a Medicare-plus rate to reimburse on surprise bills, or are we going to go into arbitration. And, I think what arbitration does is really codify the practice of surprise billing, which is a way around provider agreements. Instead of patients being able to really see relief, while the bill may relieve the patients upfront, they’re going to get the [charges] in added premiums, increased deductibles, increased co-pays; so, ultimately, a patient is going to pay for a surprise bill.
We would rather see Congress act on policies that allow for a long-term, stable arrangement between providers and insurance companies, rather than have a system where an arbitrator picks one price versus the other.
In VERIFY, Rusfertide Spares Most Patients With PV a Phlebotomy for 32 Weeks, Improves QOL
June 3rd 2025Adding rusfertide to standard of care more than doubled the share of patients with polycythemia vera (PV) who did not meet criteria for a phlebotomy, according to data from the VERIFY trial.
Read More
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Depth of Responses, PFS in Transplant-Ineligible Patients Match Overall Findings in CEPHEUS
June 2nd 2025Quadruplet therapy is now the accepted standard for patients newly diagnosed with myeloma who are ineligible for transplant; there is debate whether all newly diagnosed patients should have this regimen.
Read More
Multicancer Detection Assays Remain Largely Elusive for Early-Stage Disease Detection
June 1st 2025Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple cancers from a single blood sample, enhancing patient outcomes by identifying cancers earlier.
Read More
